Stock Events

Stock Events

Nextgen Biomed 

ILA45.00
0
+ILA0.00+0%Wednesday 14:24

Statistics

Day High
45
Day Low
45
52W High
72
52W Low
0.45
Volume
10,000
Avg. Volume
5,225
Mkt Cap
490.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-489.2MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, directly competing in the biotechnology and genomics field.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific Inc. offers biotechnology product development, including life sciences solutions, analytical instruments, and diagnostics, overlapping with Nextgen Biomed's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. is involved in the discovery, development, and commercialization of pharmaceutical products for the treatment of serious medical conditions, similar to Nextgen Biomed's focus.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated researches and develops medicines in biotechnology, directly competing in the pharmaceuticals and healthcare sector.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise, competing in the biotech industry.
Biogen
BIIB
Mkt Cap37.49B
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases, competing in the biopharmaceutical field.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. researches and develops innovative pharmaceuticals, directly competing in the development of treatments for life-threatening diseases.
Novartis
NVS
Mkt Cap303.67B
Novartis AG specializes in the development of healthcare products, directly competing with Nextgen Biomed in multiple therapeutic areas.
Pfizer
PFE
Mkt Cap173.95B
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. provides healthcare solutions and is involved in the development of pharmaceuticals, competing in the global healthcare market.

About

Nextgen Biomed Ltd, a pharmaceutical company, develops medicines for the treatment of psoriasis. Its lead product is DPS-101, a non-steroidal treatment for psoriasis that is in Phase II/III trials. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is headquartered in Tel Aviv, Israel.
Show More
CEO
Mr. Uri Zenko
Country
Other
ISIN
IL0010839301

Listings

TA
IL
NXGN-M.TA

0 Comments

Share your thoughts

FAQs

What is Nextgen Biomed stock price today?▼
The current price of NXGN-M.TA is ILA45.00 ILA — it has increased by +0% in the past 24 hours. Watch Nextgen Biomed stock price performance more closely on the chart.
What is Nextgen Biomed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tel Aviv Exchange exchange Nextgen Biomed stocks are traded under the ticker NXGN-M.TA.
What is Nextgen Biomed market cap?▼
Today Nextgen Biomed has the market capitalization of 490.55M
What is Nextgen Biomed revenue for the last year?▼
Nextgen Biomed revenue for the last year amounts to 0 ILA.
What is Nextgen Biomed net income for the last year?▼
NXGN-M.TA net income for the last year is -489.2M ILA.
In which sector is Nextgen Biomed located?▼
Nextgen Biomed operates in the Energy sector.
When did Nextgen Biomed complete a stock split?▼
The last stock split for Nextgen Biomed was on September 3, 2023 with a ratio of 1:6.
Where is Nextgen Biomed headquartered?▼
Nextgen Biomed is headquartered in Tel Aviv, Other.